Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project
Publication date
2025-10-05
Authors
Mølgaard-Nielsen, Ditte
Mitter, Vera
Lupattelli, Angela
Hoxhaj, Vjola
Andaur Navarro, Constanza L.
Hayati, Saeed
Lopez-Leon, Sandra
Morris, Joan K.
Geldof, Anja
Jordan, Susan
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Objective To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic healthcare databases and evaluate their impact on the estimated prevalence. Design Multi-national cohort study using routinely collected electronic healthcare data Setting National and regional databases in five European countries (Norway, Finland, Italy, Spain and France), in primary and/or secondary care. Participants Pregnancy cohorts resulting in stillbirths or live births between 2009 and 2020, comprising 602 897 pregnancies in Norway, 507 904 in Finland, 374 009 in Italy, 193 495 in Spain and 116 762 in France. Primary and secondary outcomes The primary outcome was the prevalence of GDM identified using six algorithms: (1) Only diagnosis; (2) Diagnosis or prescription; (3) Two diagnoses or prescriptions (2DxRx); (4) Diagnosis including unspecified diabetes in pregnancy or prescription (DxRx broad); (5) Diagnosis excluding pre-existing diabetes in pregnancy or prescription; (6) Registration of GDM in a birth registry (BR). Results The strictest algorithm (2DxRx) resulted in the lowest GDM prevalence, while the broadest (DxRx broad) resulted in the highest, except in France where it was BR. In the Nordic countries, GDM prevalence varied only slightly by algorithm; greater variations were observed in other countries. The prevalence ranged from 3.5% (95% CI: 3.5% to 3.5%) to 4.6% (95% CI: 4.5% to 4.7%) in Norway; 12.1% (95% CI: 12.0% to 12.2%) to 15.8% (95% CI: 15.7% to 15.9%) in Finland, where prevalence was much higher than elsewhere. The prevalence ranged from 1.3% (95% CI: 1.3% to 1.3%) to 5.4% (95% CI: 5.3% to 5.5%) in Italy; 1.6% (95% CI: 1.5% to 1.7%) to 6.2% (95% CI: 6.1% to 6.3%) in Spain; and 1.7% (95% CI: 1.6% to 1.8%) to 5.8% (95% CI: 5.7% to 5.9%) in France. Conclusions In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.
Keywords
Diabetes in pregnancy, Electronic Health Records, Pregnancy, General Medicine, SDG 3 - Good Health and Well-being
Citation
Mølgaard-Nielsen, D, Mitter, V, Lupattelli, A, Hoxhaj, V, Andaur Navarro, C L, Hayati, S, Lopez-Leon, S, Morris, J K, Geldof, A, Jordan, S, Leinonen, M K, Martikainen, V, Manfrini, M, Cammarota, L, Neville, A, Barrachina-Bonet, L, Cavero-Carbonell, C, García-Villodre, L, Caillet, A, Beslay, M, Damase-Michel, C, van Gelder, M M H J & Nordeng, H 2025, 'Identification of gestational diabetes mellitus in European electronic healthcare databases : insights from the ConcePTION project', BMJ Open, vol. 15, no. 10, e102343, pp. 1-12. https://doi.org/10.1136/bmjopen-2025-102343